Emyria

(ASX) EMD

Current PriceA$0.04

Market CapA$33.88M

Since IPO (2020)-71%

5 Year-78%

1 Year+83%

1 Month+0%

Emyria Financials at a Glance

Market Cap

A$33.88M

Revenue (TTM)

A$3.95M

Net Income (TTM)

-A$6.18M

EPS (TTM)

-A$0.01

P/E Ratio

-5.12

Dividend

A$0.00

Beta (Volatility)

-0.08 (Low)

Dividend

A$0.00

Beta (Volatility)

-0.08 (Low)

Price

A$0.04

Volume

795,986

Open

A$0.04

Price

A$0.04

Volume

795,986

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.02 - A$0.08

Estimated Earnings Date

Sep 1, 2026

Dividend

A$0.00

Beta (Volatility)

-0.08 (Low)

Price

A$0.04

Volume

795,986

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.02 - A$0.08

Estimated Earnings Date

Sep 1, 2026

EMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Emyria

Industry

Pharmaceuticals

Sector

Health Care

CEO

Michael Winlo, MD, MBA

Website

emyria.com

Headquarters

Leederville, WA 6007, AU

EMD Financials

Key Financial Metrics (TTM)

Gross Margin

-57%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-59%

Return on Capital

-32%

Return on Assets

-33%

Earnings Yield

-19.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$33.88M

Shares Outstanding

806.56M

Volume

795.99K

Avg. Volume

2.42M

Financials (TTM)

Gross Profit

A$24.49K

Operating Income

-A$2.65M

EBITDA

-A$2.39M

Operating Cash Flow

-A$2.70M

Capital Expenditure

-A$13.89K

Free Cash Flow

-A$2.72M

Cash & ST Invst.

A$3.57M

Total Debt

A$613.50K

Emyria Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$1.44M

+32.1%

Gross Profit

-A$1.33M

+16.6%

Gross Margin

-92.22%

N/A

Market Cap

A$33.88M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-A$2.37M

+78.0%

EBITDA

-A$2.29M

+82.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$10.50M

+434.1%

Total Debt

A$1.06M

-64.3%

Accounts Receivable

A$249.55K

+364.1%

Inventory

A$0.00

N/A

Long Term Debt

A$1.00M

+34.1%

Short Term Debt

A$55.30K

-97.5%

Return on Assets

-33.31%

N/A

Return on Invested Capital

-32.07%

N/A

Free Cash Flow

-A$2.09M

+53.7%

Operating Cash Flow

-A$2.04M

+54.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EYE.AXNova Eye Medical Limited

EYE.AXNova Eye Medical LimitedA$0.12+6.67%

IIQ.AXINOVIQ Ltd

IIQ.AXINOVIQ LtdA$0.32+0.00%

BDX.AXBCAL Diagnostics Limited

BDX.AXBCAL Diagnostics LimitedA$0.07+2.94%

NXS.AXNext Science Limited

NXS.AXNext Science LimitedA$0.15+0.00%

LGP.AXLittle Green Pharma Ltd

LGP.AXLittle Green Pharma LtdA$0.08+9.33%

DOC.AXDoctor Care Anywhere Group PLC

DOC.AXDoctor Care Anywhere Group PLCA$0.12+0.00%

MAP.AXMicroba Life Sciences Limited

MAP.AXMicroba Life Sciences LimitedA$0.05-26.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About EMD

What is the current price of Emyria?

Emyria is trading at A$0.04 per share.

What is the 52-week range for Emyria?

Over the past 52 weeks, Emyria has traded between A$0.02 and A$0.08.

How much debt does Emyria have?

As of the most recent reporting period, Emyria reported total debt of A$613.50K.

How much cash does Emyria have on hand?

Emyria reported A$3.57M in cash and cash equivalents in its most recent financial results.

What is Emyria’s dividend yield?

Emyria does not currently have a dividend yield.

Emyria

Emyria Financials at a Glance

EMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Emyria

EMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Emyria Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EMD

What is the current price of Emyria?

What is the 52-week range for Emyria?

How much debt does Emyria have?

How much cash does Emyria have on hand?

What is Emyria’s dividend yield?

Premium Investing Services